Mid-Atlantic CVTeam
MACCS CVTeam Education
The Late Breakers: What you must know from ACC.26
Get up to speed on the top late breaking clinical trials that were presented in New Orleans at ACC.26. Grab your cup of coffee, log on and quickly understand what your patients are going to be asking about and how it applies to your practice. This free session will enlighten and be enjoyable.
Click here and use this passcode: y!%.8071 to view a recording of the meeting.
ACCREDITATION INFORMATION
Click here for accreditation information, including the link for CEUs.
|
8:00am |
Welcome |
|
8:00-8:40am |
Atrial fibrillation/Pulmonary HypertensionModerator Maureen Julien, CRNP, MSN CVTeam Representative, Eastern PA |
|
|
Outcomes in Patients with Atrial Fibirllation Randomized to Receive Left Atrial Appendage Closure of Oral Anticoagulation: Primary Results of the Champion AF Clinical Trial Robert Hipp PA-C University of Pennsylvania |
|
|
HI-Peitho Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute PE Jennifer Fox, CRNP Lancaster General Hospital |
|
|
Efficacy and Safety of Sotarecept in Combined Post and Pre-Capillary Pulmonary HTN Associated with Heart Failure with Preserved Ejection Fraction: Results from the Phase 2 Cadence Trial Jennifer Kliner, DNP, CRNP University of Pittsburgh Medical Center Presbyterian |
|
|
Evolocumab in Patients without Significant Atherosclerosis: Results from VESALIUS-CV Gayley Webb, CRNP University of Pennsylvania |
|
8:40-9:20am |
Heart FailureModerator Genise Green, MSN, CRNP |
|
|
Mavacamten in Symptomatic Adolescent Patients with Obstructive Hypertrophic Cardiomyopathy: Results From the Phase 3 Scout HCM-Trial Elizabeth M. Luttner, MS, MPAS, PA-CHypertrophic Cardiomyopathy and Cardiac Amyloidosis Centers UPMC Heart and Vascular Institute |
|
|
Long Term Survival Benefits and Disease Stabilization with Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Elizabeth M. Luttner, MS, MPAS, PA-CHypertrophic Cardiomyopathy and Cardiac Amyloidosis Centers UPMC Heart and Vascular Institute |
|
Safety and Preliminary Efficacy of AAVrh.10hFXN (LX206) Gene Therapy in in Freidrich Ataxia Cardiomyopathy Maria Molina, CRNP University of Pennsylvania Medical Center |
|
|
NOTIFY-HF: A Randomised Pilot Trial of Patient -facing Heart Logic Alerts in Heart Failure Patients Amber Valimont, CRNP University of Pittsburgh Medical Center |
|
9:20-10:00am
|
Pharmacological UpdatesSteven Dunn, PharmD University of Virginia Health |
|
|
Effects of Tirzepatide compared to Dulaglutide on expanded cardiorenal outcomes 10 yr follow up of Clopidogrel v Aspirin monotherapy in stable coronary artery disease after PCI with DES Spironolactone in the Treatment of Heart Failure
Digoxin in Rheumatic Heart Disease: A Multi Center Randomized, Double Blind, Placebo controlled trial |
Maryland Chapter, American College of Cardiology 1783 Forest Drive, Suite 238 Annapolis, MD 21401 |